Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

ESS and MAX IV Summit 2024

Organised by: ESS/MAX IV-kansliet
Entreprenörsstråket 21, 431 53 Mölndal, Sweden, Mölnlycke Health Care HQ i Mölndal och digitalt via Youtube Thu 17 Oct 2024 at 09:00-16:00

The theme for summit 2024 is Life Sciences - from structural biology to medical technology. We will discuss how ESS and MAX IV can strengthen the Swedish life science and medical technology sector. And how resources for education, labs and data analysis must reflect the needs of both academia and industry to make this happen.

This web page has been machine translated. If there are any uncertainties, please refer to the Swedish text.

Please note: October 7 is the last day to register for on-site participation.

For those who want to participate digitally, the meeting will be webcast here

Facilities such as MAX IV and ESS have for many years been used to study drug candidates for, for example, type 2 diabetes and immunotherapies for cancer treatment. Other examples of research conducted at these research infrastructures can be about improving the thermal stability of biopharmaceutical products or packaging mRNA in nanoparticles for vaccines.

The program is held in English.

09:00 Welcome to the Summit!
Darja Isaksson, director general, Vinnova
Katarina Bjelke, director general, Swedish Research Council

09:15 Welcome to Mölnlycke Health Care and GoCo Health Innovation City
Zlatko Rihter, CEO, Mölnlycke Health Care
Jacob Thorell, CEO, Steptura

09:30 Framtidens Life Sciences and MedTech in Sweden
Fredrik Wessberg, CEO, CCRM Nordic
Hanna Barriga, docent, KTH, SciLifeLab
Zlatko Rihter, CEO, Mölnlycke Health Care
Jan Ellenberg, director, SciLifeLab

10:15 MAX IV in brief
Olof Karis, director, MAX IV

11:15 Big science – a tool to make Sweden even better?
Marianna Yanez Arteta, Associate Director at Advanced Drug Delivery-divisionen within Pharmaceutical Sciences, AstraZeneca
Erik Lindahl, professor of biophysics, Stockholm University
Federica Sebastiani, Tenure Track Assistant Professor, University of Copenhagen
Chris Schlenk, Group Vice President, Wellspect Healthcare

12:00 ESS in brief
Helmut Schober, director general, ESS

13:00 Workshop at Mölnlycke HQ

13:45 Summary and discussion of the workshop

14:15 Education, laboratories, data analysis - who is responsible for what?
Pia Kinhult, Head of Host State Relations, ESS
Oliver Billker, Director, Laboratory for Molecular Infectious Medicine Sweden
Selma Maric, Director, ARI4Sweden
Jon Sporring, Co-lead, QIM Center

15:00 Conditions for life Scientific research in Sweden
Maria Nilsson, State Secretary, Ministry of Education

15:30 Summary
Darja Isaksson, director general, Vinnova
Katarina Bjelke, director general, Swedish Research Council

Moderator for the event is Maria Borelius.

Please note that this is a hybrid meeting and is held both physically and digitally. If you are interested in participating on site, you are welcome to send a request via the green notification button above. The last day for registration is then 7 October.

Read the full program for the ESS/MAX IV Summit 2024

Sometimes we photograph or video record our activities. If you don't want to participate in photos or videos, please let us know when you arrive.

Questions?

ESS/MAX IV-kansliet

Don't miss a thing - follow us in our newsletters and channels

We talk about exciting innovations, funding, events and how your organization can become more innovative.

Subscribe to our newsletter and follow us on our channels

Last updated 17 October 2024